On October 24, 2017 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, reported that the Company expects to report the financial results for the third quarter of 2017 after 5:00 PM ET on Monday, November 6, 2017 (Press release, Supernus, OCT 24, 2017, View Source [SID1234521133]).

Jack Khattar, President and Chief Executive Officer, and Greg Patrick, Chief Financial Officer, will host a conference call to present the third quarter 2017 business results on Tuesday, November 7, 2017 at 9:00 AM ET. Following the management presentation, the call will be open for questions.

A live webcast will be available at www.supernus.com.

Please refer to the information below for conference call dial-in information. Callers should dial in approximately 10 minutes prior to the start of the call.

Conference dial-in: (877) 288-1043
International dial-in: (970) 315-0267
Conference ID: 2899017
Conference Call Name: Supernus Pharmaceuticals 3Q 2017 Earnings Conference Call
Following the live call, a replay will be available on the Company’s website under the ‘Investors’ section. The webcast will be available on the Company’s website for 60 days following the live call.